Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × HA 22 × Other hematologic neoplasm × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Hairy Cell 1 Leukemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 23 Rituximab 18 Cyclophosphamide 16 fludarabine phosphate 15 Mycophenolic Acid 14 Tacrolimus 13 Cyclosporine 13 Filgrastim 11 Whole-Body Irradiation 10 Therapeutics 10 Psychiatric Rehabilitation 9 Etoposide 9 Radiotherapy 8 Methotrexate 8 Flow Cytometry 8 Methylprednisolone 7 Busulfan 7 Antilymphocyte Serum 7 Polymerase Chain Reaction 6 Cladribine 6 immunotoxin HA22 5 Lenalidomide 5 obinutuzumab 4 Vorinostat 4 Vemurafenib 4 Melphalan 4 Granulocyte Colony-Stimulating Factor 4 Cord Blood Stem Cell Transplantation 4 merphos 3 ibrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03501615 2020-06-29

MOXE

AstraZeneca

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡